Company / PP&E per Share
Alaunos Therapeutics, Inc. PP&E per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.06
FY2025
5-year range
$0.00 / $0.06
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share returned to growth in FY2025 after 4 years of decline, reaching $0.06.
Based on SEC 10-K filings.
0.06 in FY2025 with a 5-year CAGR of +0.2%.
Improved from $0.00 to $0.06 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +13.2%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Lowest pp&e per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.00 | -99.7% |
| FY2022 | $0.04 | -23.2% |
| FY2021 | $0.05 | -9.4% |
| FY2020 | $0.06 | +716.6% |
| FY2019 | $0.01 | -10.4% |
| FY2018 | $0.01 | -20.1% |
| FY2013 | $0.01 | -66.6% |
| FY2012 | $0.03 | +22.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026